Biotech tax cut and trachoma feature in Federal Budget

A tax cut for medical and biotech companies generating income from new patents developed in Australia, a further expansion of a traineeship wage subsidy and $19.1 million towards trachoma elimination are the main 2021-22 Federal Budget announcements affecting the ophthalmic sector.
Read More